Affiliation:
1. United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011, USA. LTC_george_anderson@ftdetrck-ccmail.army.mil.
Abstract
The purified recombinant V antigen from Yersinia pestis, expressed in Escherichia coli and adsorbed to aluminum hydroxide, an adjuvant approved for human use, was used to immunize outbred Hsd:ND4 mice subcutaneously. Immunization protected mice from lethal bubonic and pneumonic plague caused by CO92, a wild-type F1+ strain, or by the isogenic F1- strain C12. This work demonstrates that a subunit plague vaccine formulated for human use provides significant protection against bubonic plague caused by an F1- strain (C12) or against substantial aerosol challenges from either F1+ (CO92) or F1-(C12) Y. pestis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference48 articles.
1. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cellmediated immunity;Allison A. C.;J. Immunol. Methods,1986
2. Anderson G. W. Jr. P. L. Worsham C. R. Bolt G. P. Andrews S. L. Welkos A. M. Friedlander and J. P. Burans. Passive immunization with monoclonal antibodies against the F1 antigen of Yersinia pestis protects mice from fatal bubonic and pneumonic plague. Submitted for publication.
3. Andrews G. P. Unpublished data.
4. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge;Andrews G. P.;Infect. Immun.,1996
5. Evaluation of a microchip implant system used for animal identification in rats;Ball D. J.;Lab. Anim. Sci.,1991
Cited by
197 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献